Mazur Leonard L

CIK 00014634144 companiesMONTGOMERYVILLE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001463414

Recent Transactions

50 trades

Award
CITIUS ONCOLOGY, INC.$CTOR
Common Stock
2025-09-19+1,700,000→ 1,700,000 total
Award
CITIUS ONCOLOGY, INC.$CTOR
Common Stock
2025-09-19+1,700,000→ 1,700,000 total
Award
CITIUS ONCOLOGY, INC.$CTOR
Common Stock
2025-09-19+1,700,000→ 1,700,000 total
Disposition to Issuer
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2025-08-08−125,490→ 0 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2025-08-08+125,490→ 125,490 total
Disposition to Issuer
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2025-08-08−89,388→ 0 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2025-08-08+89,388→ 89,388 total
Award
CITIUS ONCOLOGY, INC.$CTOR
Stock Option (Right to Buy)
2024-12-12+800,000→ 800,000 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Stock Option (Right to Purchase Common Stock)
2024-11-07+600,000→ 600,000 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2024-09-25+2,234,700→ 2,234,700 total
Disposition to Issuer
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2024-09-25−2,234,700→ 0 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2024-08-14+3,137,255→ 3,137,255 total
Disposition to Issuer
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2024-08-14−3,137,255→ 0 total
Award
CITIUS ONCOLOGY, INC.$CTOR
Stock Option (Right to Buy)
2024-08-12+1,233,333→ 1,233,333 total
Award
CITIUS ONCOLOGY, INC.$CTOR
Stock Option (Right to Buy)
2024-08-12+3,700,000→ 3,700,000 total
Award
Canton Strategic Holdings, Inc.$CNTN
Options (right to buy)
2024-08-09+2,353→ 27,353 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2024-04-03+1,165,048→ 1,165,048 total
Disposition to Issuer
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2024-04-03−1,165,048→ 0 total
Award
Canton Strategic Holdings, Inc.$CNTN
Options (right to buy)
2023-11-07+25,000→ 25,000 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Option to Purchase Common Stock
2023-10-10+550,000→ 550,000 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Option to Purchase Common Stock
2022-10-04+550,000→ 550,000 total
Award
Canton Strategic Holdings, Inc.$CNTN
Options (right to buy)
2022-03-21+50,000→ 50,000 total
Conversion
Canton Strategic Holdings, Inc.$CNTN
Convertible Note
2022-01-14→ 0 total
Conversion
Canton Strategic Holdings, Inc.$CNTN
Common Stock
2022-01-14$3.20/sh+98,733→ 98,733 total
Purchase
Canton Strategic Holdings, Inc.$CNTN
Common Stock
2022-01-14$4.00/sh+25,000→ 123,733 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Option to Purchase Common Stock
2021-10-11+650,000→ 650,000 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Options to Purchase Common Stock
2021-07-22+300,000→ 300,000 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Options to Purchase Common Stock
2020-10-06+200,000→ 200,000 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Options to Purchase Common Stock
2019-10-08+175,000→ 175,000 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2019-09-27+2,234,700→ 2,234,700 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Common Stock
2019-09-27$0.90/sh+2,234,700→ 10,255,343 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2019-04-03+1,165,048→ 1,615,048 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Common Stock
2019-04-03$1.54/sh+1,165,048→ 8,020,643 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Options to Purchase Common Stock
2018-09-04+150,000→ 150,000 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2018-08-13+3,137,255→ 3,137,255 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Common Stock
2018-08-13$1.27/sh+3,137,255→ 6,855,595 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2018-03-29+167,504→ 167,504 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Common Stock
2018-03-29$2.98/sh+167,504→ 3,718,340 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Options to Purchase Common Stock
2017-09-15+40,000→ 40,000 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2017-08-24$0.54/sh+11,000→ 11,000 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Common Stock
2017-08-24$2.68/sh+11,000→ 3,337,730 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Common Stock
2017-08-08$4.13/sh+421,400→ 1,779,663 total
Conversion
Citius Pharmaceuticals, Inc.$CTXR
Common Stock
2017-08-08$3.09/sh+1,547,067→ 3,326,730 total
Conversion
Citius Pharmaceuticals, Inc.$CTXR
Convertible Promissory Note
2017-08-08−1,547,067→ 0 total
Award
Citius Pharmaceuticals, Inc.$CTXR
Convertible Promissory Note
2017-08-08+1,547,067→ 1,547,067 total
Purchase
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2017-08-08$0.01/sh+421,400→ 421,400 total
Other
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2016-03-30+0→ 5,134,748 total
Other
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2016-03-30+0→ 5,406,333 total
Other
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2016-03-30+0→ 3,668,978 total
Other
Citius Pharmaceuticals, Inc.$CTXR
Warrant to Purchase Common Stock
2016-03-30+0→ 3,594,217 total

Companies

Recent Filings

Address

147 KEYSTONE DRIVE

MONTGOMERYVILLE, PA, 18936

View on SEC.gov